LY2857785 - ≥97% , CAS No.1619903-54-6

CAS: 1619903-54-6 Cat. No.: L413766 Molecular Weight: 448.6
AVAILABLE TO ORDER
GRADE & PURITY ≥97%
Synonyms
(1r,4r)-N1-(4-(3-isopropyl-2-methyl-2H-indazol-5-yl)pyrimidin-2-yl)-N4-(tetrahydro-2H-pyran-4-yl)cyclohexane-1,4-diamine
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
 ·  off list, applied to all prices below.
Size
Status
Price
Qty
1mg
L413766-1mg
8-12 wks(?) Production requires sourcing of materials. We appreciate your patience and understanding.
$52.90
5mg
L413766-5mg
3
$188.90
10mg
L413766-10mg
2
$250.90
25mg
L413766-25mg
2
$334.90
50mg
L413766-50mg
2
$635.90
100mg
L413766-100mg
8-12 wks(?) Production requires sourcing of materials. We appreciate your patience and understanding.
$1,144.90
Enter a quantity for the sizes you want to add.
🧪

Why this grade

≥97% for sensitive chromatographic and analytical workflows requiring minimal baseline interference.

🌡

Storage & shipping

Store at -20°C Ships Ice chest + Ice pads Check lot-specific COA for exact specifications.

📋

Quality documents

SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.

📚

Literature proof

Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.

Overview

Information

LY2857785 is a type I reversible and competitive ATP kinase inhibitor againstCDK9(IC50=0.011 μM) and also inhibits other transcription kinasesCDK8(IC50=0.016 μM) andCDK7(IC50=0.246 μM).


Targets

CDK9 (Cell-free assay); CDK8 (Cell-free assay); CDK7 (Cell-free assay) 0.011 μM; 0.016 μM; 0.246 μM


In vitro

LY2857785 shows good selectivity against a panel of 114 protein kinases, with only 5 other protein kinases inhibited with potency (IC50) less than 0.1 μmol/L, and a total of 14 kinases less than 1 μmol/L. At the cellular level, LY2857785 inhibits CTD P-Ser2 and CTD P-Ser5 in U2OS cells at IC50s 0.089 and 0.042 μM. Although LY2857785 inhibits CDK4, CDK6, and CDK2 enzymatic activities, it does not induce G1-S cell-cycle arrest. It also has activity against CDK1 (Histone H1 P-T153 inhibition IC50 0.241 μmol/L). However LY2857785 only induces a moderate G2–M DNA content increase, from 35% to 55%, with EC50 0.135 μmol/L. LY2857785 inhibits hematologic and solid tumor cell proliferation and induces apoptosis in vitro.


In vivo

LY2857785 inhibits RNAP II CTD Ser2 phosphorylation in vivo. It demonstrates potent antitumor growth efficacy in preclinical tumor models and increases animal survival. No significant weight loss is observed in the nude mouse study while animal mortality is observed in these studies at LY2957785 high-dose groups.


Cell Research(from reference)

Cell lines:Solid tumor cells/hematologic cell lines; i.e. Human A549 (lung carcinoma), U2OS (osteosarcoma), HCT116 (colorectal carcinoma), U87MG (glioblastoma), A375 (malignant melanoma), MV-4-11 (biphenotypic B-myelomonocytic leukemia), RPMI 8226 (myelo 

Concentrations:0, 0.1, 0.2, 0.4, 0.6, 0.8, 1 μM 

Incubation Time:2-72 h 

Specifications

Synonyms
(1r, 4r)-N1-(4-(3-isopropyl-2-methyl-2H-indazol-5-yl)pyrimidin-2-yl)-N4-(tetrahydro-2H-pyran-4-yl)cyclohexane-1, 4-diamine
Specifications & Purity
≥97%
Biochemical and Physiological Mechanisms
LY2857785 is a type I reversible and competitive ATP kinase inhibitor against CDK9(IC50=0.011 μM) and also inhibits other transcription kinases CDK8(IC50=0.016 μM) and CDK7 (IC50=0.246 μM).
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
This product requires cold chain shipping. Ground and other economy services are not available.
Action Type
ACTIVATOR
Purity
≥97%
Names and Identifiers
Pubchem Sid504772430
Pubchem Sid Urlhttps://pubchem.ncbi.nlm.nih.gov/substance/504772430
Canonical SmilesCC(C)C1=C2C=C(C=CC2=NN1C)C3=NC(=NC=C3)NC4CCC(CC4)NC5CCOCC5
IUPAC Name4-N-[4-(2-methyl-3-propan-2-ylindazol-5-yl)pyrimidin-2-yl]-1-N-(oxan-4-yl)cyclohexane-1,4-diamine
InChIKeyLHIUZPIDLZYPRL-UHFFFAOYSA-N
INCHI1S/C26H36N6O/c1-17(2)25-22-16-18(4-9-24(22)31-32(25)3)23-10-13-27-26(30-23)29-20-7-5-19(6-8-20)28-21-11-14-33-15-12-21/h4,9-10,13,16-17,19-21,28H,5-8,11-12,14-15H2,1-3H3,(H,27,29,30)
Isomeric SMILES CC(C)C1=C2C=C(C=CC2=NN1C)C3=NC(=NC=C3)NC4CCC(CC4)NC5CCOCC5
Molecular Weight 448.6
Reaxy-Rn 54605340
Reaxys-RN_link_address https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=54605340&ln=

Documentation

📋 Safety Data Sheet (SDS)

Comprehensive hazard, handling, storage, and regulatory compliance document.

Download SDS →

✅ Certificate of Analysis (COA)

Lot-specific quality data. Enter your lot number to retrieve the exact COA.

Look up COA →

📊 Datasheet

Quick-reference summary of product specifications and applications.

View datasheet →

🔬 Specification Sheet

Full quality attributes and acceptance criteria for this grade.

View spec sheet →

Advanced Data

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganoheterocyclic compounds
ClassBenzopyrazoles
SubclassIndazoles
Intermediate Tree Nodes Not available
Direct ParentIndazoles
Alternative Parents Cyclohexylamines  Aminopyrimidines and derivatives  Oxanes  Benzenoids  Pyrazoles  Heteroaromatic compounds  Oxacyclic compounds  Dialkylamines  Dialkyl ethers  Azacyclic compounds  Hydrocarbon derivatives  
Molecular FrameworkAromatic heteropolycyclic compounds
Substituents Benzopyrazole - Indazole - Aminopyrimidine - Cyclohexylamine - Oxane - Pyrimidine - Benzenoid - Pyrazole - Heteroaromatic compound - Azole - Secondary amine - Ether - Secondary aliphatic amine - Dialkyl ether - Azacycle - Oxacycle - Organic nitrogen compound - Amine - Organooxygen compound - Organonitrogen compound - Hydrocarbon derivative - Organic oxygen compound - Aromatic heteropolycyclic compound
DescriptionThis compound belongs to the class of organic compounds known as indazoles. These are compounds containing an indazole, which is structurally characterized by a pyrazole fused to a benzene.
External Descriptors Not available
3D Structure
Interactive Chemical Structure Model





Associated Targets(Human)
CDK9 Tchem Cyclin-dependent kinase 9 (2495 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK2 Tchem Cyclin-dependent kinase 2 (9050 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCNT1 Tchem CDK9/cyclin T1 (2643 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCNH Tbio CDK7/Cyclin H/MNAT1 (693 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK8 Tchem CDK8/Cyclin C (1054 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Associated Targets(non-human)
Hdac6 Histone deacetylase 6 (222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rep Replicase polyprotein 1ab (378 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mechanisms of Action
Certificates(CoA,COO,BSE/TSE and Analysis Chart)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

11 results found

Lot NumberCertificate TypeDateItem
K2527173Certificate of AnalysisDec 06, 2025 L413766
K2214678Certificate of AnalysisAug 13, 2025 L413766
K2214699Certificate of AnalysisAug 13, 2025 L413766
K2214700Certificate of AnalysisAug 13, 2025 L413766
K2214708Certificate of AnalysisAug 13, 2025 L413766
K2214709Certificate of AnalysisAug 13, 2025 L413766
G2221020Certificate of AnalysisMay 09, 2025 L413766
G2221027Certificate of AnalysisMay 09, 2025 L413766
G2221028Certificate of AnalysisMay 09, 2025 L413766
G2221029Certificate of AnalysisMay 09, 2025 L413766
J2219095Certificate of AnalysisAug 02, 2022 L413766

Show more ⌵

Chemical and Physical Properties
SolubilitySolubility (25°C) In vitro Ethanol: 42 mg/mL (93.62 mM); DMSO: 23 mg/mL (51.27 mM); Water: Insoluble;
Molecular Weight448.600 g/mol
XLogP34.300
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count6
Rotatable Bond Count6
Exact Mass448.295 Da
Monoisotopic Mass448.295 Da
Topological Polar Surface Area76.900 Ų
Heavy Atom Count33
Formal Charge0
Complexity606.000
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Solution Calculators
Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.